Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/13/2025
Innovative Antibody Therapeutic Development in China Compared with the...
11/12/2025
Brightintel Secures Multi-Million CNY Series Pre-A Funding to Advance ...
11/12/2025
DeliNova Raises CNY 60M in Seed and Angel Financing to Advance In Vivo...
11/12/2025
Aureka Closes Multi-Million-Dollar Series A to Advance Pipeline and AI...
11/12/2025
Brise Secures Over CNY 200M Series A to Advance Pain Management Pipeli...
11/12/2025
Lyell Acquires Global Rights to ICT's Next-Generation CAR-T Therapy LY...
11/12/2025
Rona Thera Unveils Promising Phase 1 Data for Long-Acting APOC3 siRNA ...
11/12/2025
BeOne Launches Global Phase 1 Trial of FIC CDK2 Degrader BG-75098
11/12/2025
Indian Pharma Firms Secure Key Wins in China's Latest VBP Round
11/11/2025
AZ's Evinova and Harbour BioMed Form AI Partnership to Advance Biologi...
11/11/2025
MeiraGTx and Eli Lilly Form Strategic Partnership to Advance Gene Ther...
11/11/2025
Huahui to Present 48-Week Phase 2b Data of Libevitug at AASLD 2025
11/11/2025
Innovent and SanegeneBio Present Positive Phase 1 Data for siRNA Thera...
11/11/2025
SanegeneBio and Eli Lilly Form RNAi Collaboration in Metabolic Disease...
11/11/2025
Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...
11/11/2025
Nona and Umoja Expand Partnership to Advance In‑Vivo CAR‑T Cell Ther...
11/11/2025
China Approves CPEB's Pediatric CAR‑T Therapy for r/r B‑ALL
11/11/2025
3SBio Presents Encouraging Phase 2 Results for SSGJ‑707 at SITC 2025
11/11/2025
Glenmark Gains NMPA Approval for RYALTRIS®
11/11/2025
Simcere to Manufacture Idorsia's Insomnia Drug in China
11/11/2025
China Launches National Strategy to Integrate AI Across Healthcare Sys...
11/11/2025
Zydus Receives China NMPA Approval for Venlafaxine ER Capsules
11/11/2025
Chinese Innovative Drug Companies Report Strong Q3 Results
11/11/2025
CDE Opens Public Consultation on Draft Guidelines for Recombinant Mono...
11/11/2025
CDE Reopens Consultation on Influenza Vaccine Clinical Trial Guideline...
11/11/2025
CDE Solicits Comments on Revised HPV Vaccine Clinical Trial Guidelines
11/11/2025
CDE Issues Technical Guidelines for Pharmaceutical Research and Evalua...
11/11/2025
CDE Seeks Feedbacks on Clinical Trial Guidelines for Adhesion and Irri...
11/7/2025
Correctseq Reports World's First Gene-Editing Treatment for Hyperlipid...
11/7/2025
Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...
Page:
6
/
805
Total number of articles:
24122
:
[First]
[<<]
[4]
[5]
[6]
[7]
[8]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit